Cargando…

CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation

Gallbladder carcinoma (GBC) is the fifth most common malignancy of gastrointestinal tract. The prognosis of gallbladder carcinoma is extremely terrible partially due to metastasis. However, the mechanisms underlying gallbladder carcinoma metastasis remain largely unknown. CD133 is a widely used canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chen, Wang, Cong, Xing, Yang, Zhen, Jiaojiao, Ai, Zhilong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951247/ https://www.ncbi.nlm.nih.gov/pubmed/26910892 http://dx.doi.org/10.18632/oncotarget.7474

Ejemplares similares

Galectin-3 induced by hypoxia promotes cell migration in thyroid cancer cells
por: Zheng, Jiaojiao, et al.
Publicado: (2017)

Elongator promotes the migration and invasion of hepatocellular carcinoma cell by the phosphorylation of AKT
por: Xu, Yi, et al.
Publicado: (2018)

Filamin A phosphorylation by Akt promotes cell migration in response to arsenic
por: Li, Lingzhi, et al.
Publicado: (2015)

Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway
por: Shen, Sheng, et al.
Publicado: (2016)

Osthole resensitizes CD133(+) hepatocellular carcinoma cells to cisplatin treatment via PTEN/AKT pathway
por: Ye, Junfeng, et al.
Publicado: (2020)

CD133(+) cancer stem-like cells promote migration and invasion of salivary adenoid cystic carcinoma by inducing vasculogenic mimicry formation
por: Wang, Sha-sha, et al.
Publicado: (2016)

TTK activates Akt and promotes proliferation and migration of hepatocellular carcinoma cells
por: Liu, Xing, et al.
Publicado: (2015)

Rictor promotes cell migration and actin polymerization through regulating ABLIM1 phosphorylation in Hepatocellular Carcinoma
por: Dong, Xin, et al.
Publicado: (2020)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT
por: Li, Xinxing, et al.
Publicado: (2017)

Phosphorylation of SMC1A promotes hepatocellular carcinoma cell proliferation and migration
por: Zhang, Ying, et al.
Publicado: (2018)

Inhibition of CD133 Overcomes Cisplatin Resistance Through Inhibiting PI3K/AKT/mTOR Signaling Pathway and Autophagy in CD133-Positive Gastric Cancer Cells
por: Lu, Ruiqi, et al.
Publicado: (2019)

APEX1 predicts poor prognosis of gallbladder cancer and affects biological properties of CD133(+) GBC-SD cells via upregulating Jagged1
por: Wu, Zhengchun, et al.
Publicado: (2023)

Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation
por: Ku, Yun Hyi, et al.
Publicado: (2017)

CD133 in brain tumor: the prognostic factor
por: Li, Bin, et al.
Publicado: (2016)

Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation
por: Hong, Sung Woo, et al.
Publicado: (2016)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer
por: Zheng, Jiaojiao, et al.
Publicado: (2016)

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020)

Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9
por: Zhang, Bao-gui, et al.
Publicado: (2014)

Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties
por: Su, Ying-Jhen, et al.
Publicado: (2015)

CD133(+) cancer stem cells promoted by VEGF accelerate the recurrence of hepatocellular carcinoma
por: Liu, Kai, et al.
Publicado: (2017)

CXCL3 contributes to CD133(+) CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1/2 phosphorylation
por: Zhang, Lin, et al.
Publicado: (2016)

Biological characteristics of CD133(+) cells in nasopharyngeal carcinoma
por: ZHUANG, HUI-WEN, et al.
Publicado: (2013)

Expression of CD 133 in Invasive Ductal Carcinoma of Breast
por: Utnal, Preeti Ashok, et al.
Publicado: (2020)

HDAC1 promoted migration and invasion binding with TCF12 by promoting EMT progress in gallbladder cancer
por: He, Junyi, et al.
Publicado: (2016)

Galectin-1 is overexpressed in CD133(+) human lung adenocarcinoma cells and promotes their growth and invasiveness
por: Zhou, Xuefeng, et al.
Publicado: (2014)

Mutation of N-linked glycosylation at Asn548 in CD133 decreases its ability to promote hepatoma cell growth
por: Liu, Ying, et al.
Publicado: (2015)

HDAC10 promotes lung cancer proliferation via AKT phosphorylation
por: Yang, Yiwei, et al.
Publicado: (2016)

Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT
por: Ye, Jianwen, et al.
Publicado: (2021)

Transketolase promotes colorectal cancer metastasis through regulating AKT phosphorylation
por: Li, Minle, et al.
Publicado: (2022)

Hypoxia-Inducible Factors Activate CD133 Promoter through ETS Family Transcription Factors
por: Ohnishi, Shunsuke, et al.
Publicado: (2013)

The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN
por: Egawa, Hiroshi, et al.
Publicado: (2016)

Ciliary Neurotrophic Factor Promotes the Migration of Corneal Epithelial Stem/progenitor Cells by Up-regulation of MMPs through the Phosphorylation of Akt
por: Chen, Jialin, et al.
Publicado: (2016)

Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma
por: Zhang, Lin, et al.
Publicado: (2014)

Autocrine interleukin-23 promotes self-renewal of CD133(+) ovarian cancer stem-like cells
por: Wang, Dan, et al.
Publicado: (2016)

CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche
por: Roy, Lynn, et al.
Publicado: (2018)

Expression of CD133 and CD24 and their different phenotypes in urinary bladder carcinoma
por: Farid, Rola M, et al.
Publicado: (2019)

miR-200b inhibits CD133(+) glioma cells by targeting the AKT pathway
por: Liu, Aiqun, et al.
Publicado: (2017)

Expression of CD133 in endometrial cancer cells and its implications
por: Ding, Dah-Ching, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cqvc87eo3e734144ijktqbbh40